FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

395938000: Clavulanate potassium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1469878017 Clavulanate potassium (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1489570012 Clavulanate potassium en Synonym Active Entire term case insensitive SNOMED CT core module
2694206012 Potassium clavulanate en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clavulanate potassium Is a Clavulanate false Inferred relationship Existential restriction modifier
Clavulanate potassium Is a Clavulanic acid false Inferred relationship Existential restriction modifier
Clavulanate potassium Is modification of Clavulanic acid true Inferred relationship Existential restriction modifier
Clavulanate potassium Is a Substance with beta-lactam structure and antibacterial mechanism of action true Inferred relationship Existential restriction modifier
Clavulanate potassium Has disposition Antibacterial true Inferred relationship Existential restriction modifier
Clavulanate potassium Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Clavulanate potassium Is a Substance with beta-lactamase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Clavulanate potassium Has disposition Beta-lactamase inhibitor true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) 10 vial Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier
Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) 10 vial Has precise active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier 2
Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) 10 vial Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) Has precise active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier 1
Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) 21 tablet 3 x 7 tablets Has precise active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier 1
Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) 21 tablet 3 x 7 tablets Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Torrent Pharma (UK) Ltd) Has precise active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier 2
Co-amoxiclav 250mg/125mg tablets (Torrent Pharma (UK) Ltd) Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Torrent Pharma (UK) Ltd) Has precise active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier 1
Co-amoxiclav 500mg/125mg tablets (Torrent Pharma (UK) Ltd) Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Torrent Pharma (UK) Ltd) 21 tablet Has precise active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier 2
Co-amoxiclav 250mg/125mg tablets (Torrent Pharma (UK) Ltd) 21 tablet Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Torrent Pharma (UK) Ltd) 21 tablet Has precise active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier 1
Co-amoxiclav 500mg/125mg tablets (Torrent Pharma (UK) Ltd) 21 tablet Has specific active ingredient True Clavulanate potassium Inferred relationship Existential restriction modifier

Start Previous Page 9 of 9


This concept is not in any reference sets

Back to Start